BBWI Stock Forecast & Price Target

Bath & Body Works is attractive because its underlying cash generation and shareholder returns remain strong, with free cash flow up about 30% in ’25 and dividends consistently consuming the mid-to-high 20’s range of FCF, which provides downside support even as earnings have been flat to down. The company also has multiple growth levers, including a robust product pipeline, a broader loyalty rollout, continued store base optimization, digital investment, and Amazon, which has already shown strong DD% week-over-week growth and is drawing new, younger, and more affluent customers. Although BBWI is losing share in the mass fragrance category and must prove that 2H26 recovery is durable, the combination of improving innovation, emotional brand differentiation, and valuation at ~7x FY2 P/E supports a positive outlook.

Bath & Body Works is facing a fundamental demand and execution problem as body care sales fell mid-teens, while management itself acknowledged the assortment has lagged a category that has shifted toward more benefit-driven, innovation-led products. Heavy, persistent promotions across candles, soaps, sanitizers, and body care suggest the core consumer is trained to buy on deal, making it difficult to protect full-price selling or reverse the traffic and mix pressure without sacrificing demand. Those issues are already hitting profitability, with gross margin estimated at 42.4% and SG&A at 29.2% of sales, while Amazon expansion, international sales at just 4% in fiscal 2025, and new innovation in 2H26 carry meaningful execution and cannibalization risk.